Equities

Enhabit Inc

Enhabit Inc

Actions
Health CareHealth Care Providers
  • Price (USD)8.76
  • Today's Change0.00 / 0.00%
  • Shares traded121.00k
  • 1 Year change-21.99%
  • Beta--
Data delayed at least 15 minutes, as of Jul 03 2024 22:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Enhabit, Inc. is a provider of home health and hospice services. The Company’s segments include Home Health and Hospice. The Home Health segment provides a range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. Its home health business benefits from a diversity of referral sources, with patients referred from acute care hospitals, inpatient rehabilitation facilities, surgery centers, assisted living facilities, and skilled nursing facilities, as well as community physicians. The Hospice segment provides hospice services for terminally ill patients and their families. Its Medicare-certified hospice operations provide hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and family member bereavement counseling. It operates over 110 hospice agencies and 255 home health agencies.

  • Revenue in USD (TTM)1.04bn
  • Net income in USD-83.00m
  • Incorporated2014
  • Employees10.80k
  • Location
    Enhabit Inc6688 N. Central Expressway, Suite 1300DALLAS 75206United StatesUSA
  • Phone+1 (469) 621-6419
  • Fax+1 (302) 655-5049
  • Websitehttps://www.ehab.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Airsculpt Technologies Inc197.72m1.56m226.83m346.00163.212.7118.421.150.02410.02413.431.450.9593--136.64571,456.600.7588--0.8478--65.54--0.791----4.020.4602--16.07--69.49------
Viemed Healthcare Inc194.05m10.33m254.28m996.0025.672.197.541.310.25520.25524.793.001.3919.369.51194,824.307.3912.289.1415.5261.1162.575.3210.091.14146.040.05520.0031.8223.2164.631.5033.67--
Accolade Inc431.53m-88.99m278.31m2.40k--0.6394--0.6449-1.16-1.165.655.520.5253--15.98179,805.00-10.83-24.80-12.43-29.0447.4945.56-20.62-56.43----0.3242--14.0934.3078.29--31.97--
DocGo Inc703.37m21.55m303.68m2.92k15.200.98897.310.43180.19680.19686.553.021.57--3.39241,294.505.47--7.92--32.83--3.49------0.1192--41.72---80.17------
QDM International Inc6.53m1.69m352.79m3.0031.80108.32205.8854.000.0380.0380.02960.01121.81--148.49--46.82--127.17--38.10--25.81----1,761.140.2722--1,542.96--111.78------
Talkspace Inc162.13m-11.89m369.81m472.00--3.09--2.28-0.0716-0.07160.97210.70521.15--13.80343,485.20-8.40---9.68--48.95---7.33------0.00--25.49--75.92------
ModivCare Inc2.77bn-222.80m389.24m21.20k--2.87--0.1404-15.72-15.72195.509.551.50--8.59130,816.70-11.89-1.36-16.49-1.8315.7117.58-7.94-0.9619--0.39090.8906--9.8514.71-542.83--19.27--
Sonida Senior Living Inc260.69m-24.79m436.42m2.62k----28.811.67-4.66-4.6632.820.6420.4058--32.0599,612.91-2.84-6.63-3.31-8.19-----6.99-18.04---0.41020.9856--7.08-11.1155.74---3.97--
Enhabit Inc1.04bn-83.00m439.37m10.80k--0.6541--0.421-1.67-1.6720.8413.390.7022--6.3196,629.63-5.47---6.20--48.52---7.79----0.60310.438---2.32---99.26------
Community Health Systems Inc12.52bn-123.00m476.65m61.00k----0.91840.0381-0.9399-0.939995.71-10.280.86255.865.91205,295.100.20660.75660.25460.938184.2483.690.23960.93451.331.211.08--2.28-2.47-389.13---2.39--
Aveanna Healthcare Holdings Inc1.92bn-113.70m494.41m3.50k------0.2576-0.5993-0.599310.08-0.69731.14--7.45548,414.00-6.74---8.69--31.0931.12-5.92-12.71--1.841.10--6.028.6279.68---20.76--
Pediatrix Medical Group Inc2.00bn-70.58m591.56m2.90k--0.6898--0.296-0.8595-0.859524.1310.190.8907--7.11689,218.30-3.150.8579-3.570.9945-----3.531.52--4.420.45320.001.152.97-196.55--14.25--
Fulgent Genetics Inc287.53m-165.95m597.89m1.18k--0.5285--2.08-5.57-5.579.6437.800.2206--6.01242,846.30-13.2916.70-14.1618.3737.4767.89-60.2529.06----0.00140.00-53.2768.41-217.03--57.08--
Clover Health Investments Corp1.85bn-163.93m605.65m552.00--2.02--0.3269-0.339-0.33083.840.6041.74--4.673,356,643.00-15.43---49.78-------8.85-----25.390.00---41.50--37.03------
Data as of Jul 03 2024. Currency figures normalised to Enhabit Inc's reporting currency: US Dollar USD

Institutional shareholders

54.51%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 20247.38m14.71%
The Vanguard Group, Inc.as of 31 Mar 20244.56m9.09%
AREX Capital Management LPas of 31 Mar 20242.41m4.81%
JANA Partners Management LPas of 31 Mar 20242.08m4.15%
LOYS AGas of 30 Apr 20242.01m4.01%
SSgA Funds Management, Inc.as of 31 Mar 20241.99m3.97%
Van Lanschot Kempen Investment Management NVas of 31 Mar 20241.97m3.92%
Systematic Financial Management LPas of 31 Mar 20241.68m3.34%
Dimensional Fund Advisors LPas of 31 Mar 20241.64m3.26%
UBS Securities LLCas of 31 Mar 20241.63m3.25%
More ▼
Data from 31 Mar 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.